Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

DNA Copy Number Variations in Patients with 46,XY Disorders of Sex Development
Granberg, Candace F. , Keays, Mélise , Hill, Martinez, Grimsby, Gwen M. , Harrison, Steven M. , Baker, Linda A.

Journal of Urology | June 16, 2014 | Volume: 192 | Issue: 6 | Pages: 1801-1806

10.1016/j.juro.2014.06.040 | PMID 24946221 Get It

Tacrolimus dosage requirements in lung transplant recipients receiving antifungal prophylaxis with voriconazole followed by itraconazole: a preliminary prospective study
Enderby, Cher Y. , Thomas, Colleen S. , Keller, Cesar A., Heckman, Michael G.

Clinical Transplantation | June 16, 2014 | Volume: 28 | Issue: 8 | Pages: 911-915

10.1111/ctr.12403 | PMID 24931421 Get It

AbstractBackgroundConcomitant administration of the triazole antifungals, voriconazole or itraconazole, with tacrolimus can result in significant drug interaction in the transplant recipient. Limited published information exists regarding tacrolimus dosing when transitioning from voriconazole to itraconazole. The objective of this study was to evaluate the extent of the drug interaction with antifungal prophylaxis using voriconazole followed by a change to itraconazole in lung transplant recipients receiving tacrolimus.MethodsThis prospective study included lung transplant recipients receiving antifungal prophylaxis with voriconazole followed by a switch to itraconazole. Patients were followed from the time of transplant until two months after converting to itraconazole. All patients received standard immunosuppression with tacrolimus, mycophenolate mofetil, and a corticosteroid. Tacrolimus dose normalized concentrations using concentration/dose ratio were compared while receiving voriconazole versus itraconazole.ResultsTwenty lung transplant recipients were included in the final analysis. No difference was found with the tacrolimus dose normalized concentrations on voriconazole 254 ± 28 (ng/mL)/(mg/kg) compared with itraconazole 234 ± 34 (ng/mL)/(mg/kg), p = 0.65.ConclusionTacrolimus dosage adjustments were not necessary when converting from voriconazole to itraconazole. Validation in a larger population is needed to confirm these findings.
Waiting for Words
Davidson, John H.

JAMA Internal Medicine | June 16, 2014 | Volume: 174 | Issue: 8 | Pages: 1225

10.1001/jamainternmed.2014.1098 | PMID 24935410 Get It

Heavy Metal? Recognizing Complications of Metal on Metal Hip Arthroplasty
Millstine, Denise , Hakes, Hannah J., Mayer, Anita P. , Millstine, Denise M, Spangehl, Mark J.

Journal of Women's Health | June 16, 2014 | Volume: 23 | Issue: 9 | Pages: 777-779

10.1089/jwh.2014.4868 | PMID 24932678 Get It

Preoperative angiotensin axis blockade therapy, intraoperative hypotension, and the risks of postoperative acute kidney injury
Onuigbo, Macaulay , Onuigbo, Macaulay Amechi Chukwukadibia

Journal of Hospital Medicine | June 16, 2014 | Volume: 9 | Issue: 9 | Pages: 610-610

10.1002/jhm.2229 | PMID 24932783 Get It

Cystectomy for Refractory Hemorrhagic Cystitis: Contemporary Etiology, Presentation and Outcomes
Linder, Brian J. , Tarrell, Robert F., Boorjian, Stephen A. , Linder, Brian J

Journal of Urology | June 16, 2014 | Volume: 192 | Issue: 6 | Pages: 1687-1692

10.1016/j.juro.2014.06.030 | PMID 24936722 Get It

Reconstruction of the Posterolateral Corner of the Knee With Achilles Tendon Allograft
Kuzma, Scott A., Chow, Roxanne M., Engasser, William M. , Levy, Bruce A. , Stuart, Michael J.

Arthroscopy Techniques | June 16, 2014 | Volume: 3 | Issue: 3 | Pages: No page available

10.1016/j.eats.2014.02.006 | PMID 25126510 Get It

Abstract Posterolateral corner injuries of the knee are relatively rare; however, they can result in significant long‐term disability without appropriate treatment. They often occur in the setting of multiligament knee injuries, and as a result, diagnosis and management can be challenging. Severe injuries often require reconstruction, and both anatomic and nonanatomic techniques exist. We describe our preferred operative technique to reconstruct the fibular collateral ligament and posterolateral corner using a single Achilles tendon allograft. Technique Video video See video under supplementary data.
Neural control of the heart
Palma, Jose‐Alberto , Benarroch, Eduardo E. , Palma, Jose-Alberto

Neurology | June 16, 2014 | Volume: 83 | Issue: 3 | Pages: 261-271

10.1212/wnl.0000000000000605 | PMID 24928126 Get It

Active and progressive
Cross, Anne H. , Wingerchuk, Dean M. , Weinshenker, Brian G. , Weinshenker, Brian G

Neurology | June 16, 2014 | Volume: 83 | Issue: 3 | Pages: 206-207

10.1212/wnl.0000000000000601 | PMID 24928117 Get It

Palliative Oncology
Prommer, Eric

American Journal of Hospice and Palliative Medicine® | June 16, 2014 | Volume: 32 | Issue: 5 | Pages: 568-572

10.1177/1049909114539035 | PMID 24928835 Get It

Bone metastases cause devastating clinical complications leading patients to have pain, poor quality of life, loss of mobility, and autonomy. Complications from osseous metastases cause a big economic burden reflected by repeated admissions for uncontrolled symptoms. Management of symptoms associated with bone metastasis includes systemic analgesics, glucocorticoids, radiation (external beam radiation and radiopharmaceuticals), ablative techniques (radiofrequency ablation and cryoablation), chemotherapeutic agents, hormonal therapies, interventional techniques (eg, kyphoplasty), and surgical approaches. Bisphosphonates have become a standard therapy for bony metastasis. They bind to bone eventually inhibiting osteoclast action. Bisphosphonates decrease fractures when given routinely. Adverse effects of bisphosphonates include osteonecrosis of the jaw and renal insufficiency. Late last year, the Food and Drug Administration approved denosumab to prevent skeletal-related events (SREs) associated with metastatic solid tumors. This drug is a monoclonal antibody that inhibits the receptor activator of nuclear factor κB (RANK)–RANK ligand interaction. Clinical trials have shown superiority over bisphosphonates for the prevention of SREs. This article reviews the mechanism of action, pharmacology, adverse effects, and clinical trial evidence for this new drug.